New Clinical Trials in Atrial Fibrillation A Multidisciplinary Perspective
- 28 April 2026
- 21:00 Saudi Arabia Time
Overview
Atrial fibrillation (AF) management continues to evolve with the emergence of impactful clinical trials influencing strategies in stroke prevention, rhythm control, and interventional therapies.
This webinar brings together leading experts in electrophysiology and interventional cardiology to present and discuss the latest evidence, with a particular focus on left atrial appendage closure (LAAC), landmark trials such as CHAMPION, and evolving ablation strategies.
Through a focused and interactive format, participants will gain practical insights into how these trials are shaping real-world clinical decision-making.
Learning Objectives
By the end of this webinar, participants will be able to:
- Review key findings from recent clinical trials in atrial fibrillation
- Understand the evolving role of left atrial appendage closure (LAAC) in stroke prevention
- Analyze data from the CHAMPION trial and its clinical implications
- Evaluate the role of ablation in AF management based on recent subanalyses
- Apply trial evidence to optimize patient selection and treatment strategies
- Engage in multidisciplinary discussions to enhance clinical decision-making
Target Audience
- Cardiologists (General & Interventional)
- Electrophysiologists
- Internal Medicine Physicians
- Cardiology Fellows & Residents
- Allied Healthcare Professionals involved in cardiovascular care
Meet the Speakers
Prof. Jens-Erik Kudsk
Professor of Cardiology and Head of Structural Heart Interventions at Aarhus University Hospital.
Dr. Mohammad Al Hijji
Consultant in Interventional and Structural Cardiology at the Heart Hospital, Hamad Medical Corporation.
Dr. Haytham Al Anazi
Consultant Cardiac Electrophysiologist with American and Canadian board certifications.
Scientific Program
21:00 – 21:15
Opening & Current LAAC Landscape
Jens-Erik Kudsk, Denmark
21:15 – 21:20
Discussion
21:20 – 21:40
Insights into the CHAMPION Trial
Mohammad Al Hijji, Qatar
21:40 – 21:45
Discussion
21:45 – 22:00
Ablation vs No Ablation – Subanalysis Insights
Haytham Al Anazi, Saudi Arabia
22:00 – 22:05
Discussion
22:05 – 22:20
Wrap-Up & Q&A Panel Discussion
Led by: Prof. Jens-Erik Kudsk & Faculty Panel
Why To Attend?
Stay updated with the most recent AF clinical trials
Gain practical, real-world insights from leading experts
Understand how evidence translates into daily clinical practice
Engage in interactive discussions and expert-led analysis
Key Message
Three Perspectives. One Goal:
